Literature DB >> 34226361

Multifocal lesions in intraductal papillary mucinous neoplasms: Intraoperative pancreatic juice cytology.

Takao Ohtsuka1.   

Abstract

Lecture: On radiological study, 25% to 41% of the patients with intraductal papillary mucinous neoplasms (IPMNs) of the pancreas have multifocal lesions. On the other hand, in pathological assessment, most of these patients had lots of micro premalignant lesions such as small IPMNs and pancreatic intraepitehrial neoplasms (PanINs) in the background pancreas, indicating that all the pancreas having IPMNs have a potential to develop multifocal lesions. There are 3 possible types of multifocal lesions in patients with IPMNs, namely multiple branch duct IPMNs (BD-IPMNs) by multicentric development, multiple main duct or mixed type IPMNs (MD- or Mix-IPMNs) by the mechanism of intraductal dissemination of the neoplastic cells [1,2], and the development of pancreatic ductal adenocarcinoma (PDAC) concomitant with IPMNs [3,4]. Pancreatic juice cytology under endoscopic retrograde pancreatography is reported to leads early detection of concomitant PDAC during assessment of IPMNs [5], while it is often difficult to determine the location of malignant lesions when pancreatography and other imaging modalities cannot provide any significant abnormalities. Therefore, the role of intraoperative pancreatic juice cytology is to determine whether such lesions which are not detected by preoperative assessment might left in the remnant pancreas during partial pancreatectomy for IPMN. Previous report [6] demonstrated that in consecutive 48 patients who underwent intraoperative irrigation cytology in the remnant pancreas during partial pancreatectomy for IPMN, 5 patients had positive results and subsequently underwent additional resection of the pancreas. High-risk lesions including 4 PanIN-3 lesions and one invasive carcinoma were detected in all 5 additionally resected specimens. On the other hand, there might be possible patients who might have false negative result of intraoperative irrigation cytology [7] or peritoneal dissemination because of leakage of irrigation solution containing cells from high-risk lesions. In this presentation, roles and limitations of intraoperative pancreatic juice cytology will be discussed.

Year:  2021        PMID: 34226361     DOI: 10.14701/ahbps.BP-SY-1-3

Source DB:  PubMed          Journal:  Ann Hepatobiliary Pancreat Surg        ISSN: 2508-5859


  7 in total

1.  Laparoscopic surgery is applicable for larger mucinous cystic neoplasms of the pancreas.

Authors:  Takao Ohtsuka; Shunichi Takahata; Hideki Takanami; Junji Ueda; Kazuhiro Mizumoto; Shuji Shimizu; Masao Tanaka
Journal:  J Hepatobiliary Pancreat Sci       Date:  2013-09-11       Impact factor: 7.027

2.  Genetic assessment of recurrent pancreatic high-risk lesions in the remnant pancreas: Metachronous multifocal lesion or local recurrence?

Authors:  Yoshitaka Gotoh; Takao Ohtsuka; So Nakamura; Koji Shindo; Kenoki Ohuchida; Yoshihiro Miyasaka; Yasuhisa Mori; Naoki Mochidome; Yoshinao Oda; Masafumi Nakamura
Journal:  Surgery       Date:  2018-11-27       Impact factor: 3.982

3.  Molecular Evidence for Monoclonal Skip Progression in Main Duct Intraductal Papillary Mucinous Neoplasms of the Pancreas.

Authors:  Kenjiro Date; Takao Ohtsuka; Takaaki Fujimoto; Koji Tamura; Hideyo Kimura; Taketo Matsunaga; Naoki Mochidome; Tetsuyuki Miyazaki; Yasuhisa Mori; Yoshinao Oda; Masafumi Nakamura; Masao Tanaka
Journal:  Ann Surg       Date:  2017-05       Impact factor: 12.969

4.  Intraductal papillary mucinous neoplasms of the pancreas with distinct pancreatic ductal adenocarcinomas are frequently of gastric subtype.

Authors:  Noboru Ideno; Takao Ohtsuka; Hiroshi Kono; Kenji Fujiwara; Yasunori Oda; Shinichi Aishima; Tetsuhide Ito; Kousei Ishigami; Shoji Tokunaga; Kenoki Ohuchida; Shunichi Takahata; Masafumi Nakamura; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Ann Surg       Date:  2013-07       Impact factor: 12.969

5.  Treatment strategy for main duct intraductal papillary mucinous neoplasms of the pancreas based on the assessment of recurrence in the remnant pancreas after resection: a retrospective review.

Authors:  Koji Tamura; Takao Ohtsuka; Noboru Ideno; Teppei Aso; Koji Shindo; Shinichi Aishima; Kenoki Ohuchida; Shunichi Takahata; Yasuhiro Ushijima; Tetsuhide Ito; Yoshinao Oda; Kazuhiro Mizumoto; Masao Tanaka
Journal:  Ann Surg       Date:  2014-02       Impact factor: 12.969

6.  Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report.

Authors:  Koji Tamura; Takao Ohtsuka; Noboru Ideno; Teppei Aso; Hiroshi Kono; Yousuke Nagayoshi; Koji Shindo; Yasuhiro Ushijima; Junji Ueda; Shunichi Takahata; Tetsuhide Ito; Yoshinao Oda; Kazuhiro Mizumoto; Masao Tanaka
Journal:  JOP       Date:  2013-07-10

7.  Intraoperative irrigation cytology of the remnant pancreas to detect remnant distinct pancreatic ductal adenocarcinoma in patients with intraductal papillary mucinous neoplasm undergoing partial pancreatectomy.

Authors:  Yasuhisa Mori; Takao Ohtsuka; Koji Tamura; Noboru Ideno; Teppei Aso; Hiroshi Kono; Yosuke Nagayoshi; Junji Ueda; Shunichi Takahata; Shinichi Aishima; Fumihiko Ookubo; Yoshinao Oda; Masao Tanaka
Journal:  Surgery       Date:  2013-10-29       Impact factor: 3.982

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.